Randi Hernandez

Editor

Randi Hernandez is the oncology editor for Cancer Therapy Advisor. Randi has extensive experience in health care reporting and a particular interest in how medications shape the lives of patients and how treatments evolve, tracking them from scientific theory to clinical development, manufacturing stages, market release, and postmarketing studies. Prior to joining Haymarket, Randi held editing and/or writing roles at Pharmacy Times and Specialty Pharmacy Times, BioPharm International and Pharmaceutical Technology, Genetic Engineering and Biotechnology News (GEN), and BioPharma Dive.

All articles by Randi Hernandez

Black female patient talking to masked physician

Urology

Researchers Reveal Racial Disparities in Access to Remdesivir for Patients With Cancer and COVID-19

Randi Hernandez

July 27, 2020

Black patients were half as likely to receive remdesivir as White patients, according to researchers from the CCC19.

Surgery team in operating room holding scissors

Kidney Cancer

Therapeutic Advancements Have Facilitated Surgery Optimization, ASCO Officials Report

Randi Hernandez

February 5, 2020

ASCO outlined advances in oncology that were the most clinically meaningful or had the biggest scientific impact from October 2018 through September 2019.

Doctor escorting senior man down the hall

Prostate Cancer

Rural Patients May Be Less Likely to Receive Treatment for Prostate Cancer

Randi Hernandez

August 29, 2019

Simply living in a rural area made it less likely an individual with prostate cancer to receive treatment, with the exception of radiation.

Men's Health Update

Persistent Cancer Screening Gaps Revealed in New CDC Report

Randi Hernandez

August 10, 2018

From 2000 to 2015 screening for breast, cervical, and prostate cancers decreased significantly, whereas screening for colorectal cancer increased significantly.